Canada is jumping into the deep end of the international law pool with its move away from prohibition and towards the regulation of adult-use cannabis outside of medical use. This change in course is expected to more effectively curb cannabis use by children and remove a source of revenue held exclusively by criminals. It will also open an enormous new adult-use market alongside the already robust medical market for Canada’s growing cannabis industry. This industry is about to become much more visible and far larger and significant opportunities exist for both ancillary businesses and new technologies aimed at quality, compliance, and efficiency.
For context, Canada has regulated production of medical cannabis in a commercial and competitive system since 2013 under the federal Access to Cannabis for Medical Purposes Regulations, SOR/2016-230 (the “ACMPR”) (and its predecessor regulations, the Marihuana for Medical Purposes Regulations, SOR/2013-119 (the “MMPR”). As of June 29, 2018, there